DE2217965C3 - 2alpha-Methyl-17 beta-cyclopentyloxy -5 alpha-androstan-3-on, Verfahren zu seiner Herstellung sowie dieses enthaltendes Mittel - Google Patents

2alpha-Methyl-17 beta-cyclopentyloxy -5 alpha-androstan-3-on, Verfahren zu seiner Herstellung sowie dieses enthaltendes Mittel

Info

Publication number
DE2217965C3
DE2217965C3 DE19722217965 DE2217965A DE2217965C3 DE 2217965 C3 DE2217965 C3 DE 2217965C3 DE 19722217965 DE19722217965 DE 19722217965 DE 2217965 A DE2217965 A DE 2217965A DE 2217965 C3 DE2217965 C3 DE 2217965C3
Authority
DE
Germany
Prior art keywords
androstan
methyl
cyclopentyloxy
preparation
treated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19722217965
Other languages
German (de)
English (en)
Other versions
DE2217965A1 (de
DE2217965B2 (de
Inventor
Howard J. Palo Alto Calif. Ringold (V.St.A.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Palo Alto LLC
Original Assignee
Roche Palo Alto LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Palo Alto LLC filed Critical Roche Palo Alto LLC
Publication of DE2217965A1 publication Critical patent/DE2217965A1/de
Publication of DE2217965B2 publication Critical patent/DE2217965B2/de
Application granted granted Critical
Publication of DE2217965C3 publication Critical patent/DE2217965C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19722217965 1971-04-20 1972-04-14 2alpha-Methyl-17 beta-cyclopentyloxy -5 alpha-androstan-3-on, Verfahren zu seiner Herstellung sowie dieses enthaltendes Mittel Expired DE2217965C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13574371A 1971-04-20 1971-04-20

Publications (3)

Publication Number Publication Date
DE2217965A1 DE2217965A1 (de) 1972-10-26
DE2217965B2 DE2217965B2 (de) 1974-01-03
DE2217965C3 true DE2217965C3 (de) 1974-07-25

Family

ID=22469460

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722217965 Expired DE2217965C3 (de) 1971-04-20 1972-04-14 2alpha-Methyl-17 beta-cyclopentyloxy -5 alpha-androstan-3-on, Verfahren zu seiner Herstellung sowie dieses enthaltendes Mittel

Country Status (3)

Country Link
DE (1) DE2217965C3 (show.php)
FR (1) FR2133901B1 (show.php)
GB (1) GB1327910A (show.php)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use

Also Published As

Publication number Publication date
FR2133901B1 (show.php) 1975-06-20
DE2217965A1 (de) 1972-10-26
FR2133901A1 (show.php) 1972-12-01
DE2217965B2 (de) 1974-01-03
GB1327910A (en) 1973-08-22

Similar Documents

Publication Publication Date Title
DE2238540C3 (de) N-(D-6-Methyl-8-isoergoün-I-yl)-N', N'-diäthylharnstoff, dessen Salze, deren Herstellung sowie Arzneimittel
CH514578A (de) Verfahren zur Herstellung von Glucosiden
CH509297A (de) Verfahren zur Herstellung von in 17-Stellung durch ungesättigte Kohlenwasserstoffreste substituierten 11,13B-Dialkylgon-4-en-3,17B-diolen
DE2217965C3 (de) 2alpha-Methyl-17 beta-cyclopentyloxy -5 alpha-androstan-3-on, Verfahren zu seiner Herstellung sowie dieses enthaltendes Mittel
DE2426779A1 (de) 1.3-oxygenierte 8 alpha-oestratriene
DE2409675C3 (de) 5-Hydroxytryptophan-Derivate und Verfahren zu ihrer Herstellung
DE2101813C3 (de) Neue 17alpha-(2',3'-difluormethylenprop-1 '-en-1 '-yl)-östra-4-en-3-one, Verfahren zu deren Herstellung sowie diese enthaltende Mittel
DE2218000C3 (de) Neue 17 beta-Tetrahydropyran-4yloxyäther von Steroiden
CH494218A (de) Verfahren zur Herstellung von 3-Hydroxyimino-steroiden
DE1961906C3 (de) 7 a-Methyl-androstenolone, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
AT213885B (de) Verfahren zur Herstellung von neuen Indol-Derivaten
DE1543473C (de) Zearalanonhydroxylamin und Verfahren zu dessen Herstellung
AT253705B (de) Verfahren zur Herstellung von neuem 17α-Äthoxy-6-chlor-6-dehydro-progesteron
DE2008419C3 (de) Verfahren zur Herstellung von Äthylidenverbindungen
AT242304B (de) Verfahren zur Herstellung neuer Enoläther von 3-Keto-5α-androstanderivaten
AT219037B (de) Verfahren zur Herstellung neuer, basischer Indol-Derivate
DE1793685C3 (de) Helveticosidderivate
DE1793738C3 (de) 3-0A-11 beta-OB-17alpha-R-17beta-OH-östra-1,3,5 (10)-trlene und diese enthaltende Arzneimittel
AT162906B (de) Verfahren zur Herstellung von Derivaten der Cyclopentano-polyhydro-phenantren- bzw. der Polyhydro-chrysen-Reihe
DE2456655A1 (de) Naphthochinonderivate
DE2101813B2 (de) Neue 17alpha- (2 ,3 -difluormethylenprop-1 '-en-1 '-yl)-östra-4-en-3-one, Verfahren zu deren Herstellung sowie diese enthaltende Mittel
DE2311185A1 (de) Verfahren zur herstellung von phthalazon
DE1793344A1 (de) 2-Halogen-18-methyl-1-androstene
DE2218000B2 (de) Neue 17 beta-tetrahydropyran-4- yloxyaether von steroiden
DE2257413A1 (de) 17 alpha-alkinyloestradiol-3-cyclopentylaether-17-benzoate, ihre verwendung und verfahren zur herstellung derselben

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977
EHJ Ceased/non-payment of the annual fee